Zacks Research Has Optimistic Outlook of PDCO Q4 Earnings

Patterson Companies, Inc. (NASDAQ:PDCO) – Analysts at Zacks Research boosted their Q4 2025 earnings per share estimates for Patterson Companies in a research report issued on Wednesday, March 19th. Zacks Research analyst I. Bandyopadhyay now expects that the company will post earnings of $1.11 per share for the quarter, up from their previous forecast of $0.93. The consensus estimate for Patterson Companies’ current full-year earnings is $2.25 per share. Zacks Research also issued estimates for Patterson Companies’ Q3 2026 earnings at $0.61 EPS, Q3 2027 earnings at $0.60 EPS and FY2027 earnings at $2.44 EPS.

A number of other equities analysts have also commented on the company. Mizuho began coverage on Patterson Companies in a research note on Wednesday, December 4th. They set a “neutral” rating and a $23.00 price target for the company. Robert W. Baird increased their price target on Patterson Companies from $25.00 to $31.00 and gave the company a “neutral” rating in a research note on Thursday, December 12th. StockNews.com began coverage on Patterson Companies in a research note on Wednesday, March 19th. They set a “hold” rating for the company. Leerink Partnrs lowered Patterson Companies from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Stifel Nicolaus dropped their price target on Patterson Companies from $25.00 to $24.00 and set a “hold” rating for the company in a research note on Thursday, December 5th. Eleven investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $26.57.

Patterson Companies Price Performance

Shares of Patterson Companies stock opened at $31.16 on Monday. The stock has a 50 day moving average of $31.04 and a 200 day moving average of $26.23. Patterson Companies has a 12 month low of $19.45 and a 12 month high of $31.79. The firm has a market cap of $2.76 billion, a PE ratio of 18.22, a PEG ratio of 2.71 and a beta of 0.99. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34.

Institutional Investors Weigh In On Patterson Companies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PDCO. Harbour Investments Inc. purchased a new stake in shares of Patterson Companies in the fourth quarter worth approximately $26,000. Huntington National Bank raised its holdings in shares of Patterson Companies by 54.0% in the fourth quarter. Huntington National Bank now owns 1,115 shares of the company’s stock worth $34,000 after buying an additional 391 shares during the period. GAMMA Investing LLC raised its holdings in shares of Patterson Companies by 103.0% in the fourth quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock worth $41,000 after buying an additional 680 shares during the period. Anchor Investment Management LLC raised its holdings in shares of Patterson Companies by 20.5% in the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company’s stock worth $51,000 after buying an additional 400 shares during the period. Finally, Quadrant Capital Group LLC raised its holdings in shares of Patterson Companies by 501.6% in the fourth quarter. Quadrant Capital Group LLC now owns 1,883 shares of the company’s stock worth $58,000 after buying an additional 1,570 shares during the period. 85.43% of the stock is currently owned by hedge funds and other institutional investors.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.